Article Details
Retrieved on: 2024-02-25 11:37:04
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the robust growth of the global targeted protein degradation market, fueled by biotechnological advances in medicinal chemistry, such as PROTACs, for treating diseases like cancer and neurodegenerative disorders. Key market players, like Craig M. Crews, are highlighted.
Article found on: www.whatech.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here